In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regina Paleski

Set Alert for Articles By Regina Paleski

Latest From Regina Paleski

Executives On The Move: Tech And Science Announcements At Orexo And Agios, And Board Changes At Accorda And RhoVac

Swedish pharma Orexo welcomes EVP, digital health and anti-cancer therapeutics firm Agios Pharmaceuticals announces Bristol-Myers Squibb exec as its next CSO. And a chair takes a seat at Accorda Therapeutics and RhoVac.

Appointments BioPharmaceutical

Executives On The Move: Comings And Goings At JSC Olainfarm And MorphoSys, Plus A Promotion At Twist Bioscience

Latvian pharma producer JSC Olainfarm picks next CEO and chairman, and CSO is scheduled to depart German therapeutic antibody company MorphoSys. Meanwhile, synthetic DNA manufacturer Twist Bioscience promotes SVP to chief commercial officer.

Appointments BioPharmaceutical

Executives On The Move: A Finance And Development Change At EyePoint Pharma And Exits At PPD And Novartis

Ophthalmology biopharma EyePoint Pharmaceuticals confirms its new CFO and head of corporate development. A former PPD med director is now CMO of vaccine developer ILiAD Biotechnologies and neurological disorders firm Ovid Therapeutics adds ex-Novartis VP as chief commercial officer.

Appointments BioPharmaceutical

Executives On The Move: Teva Pharma Picks A CFO, Ipsen Decides On An R&D Position And Bavarian Nordic Names Its Commercial Hire

Teva Pharmaceuticals now has a new EVP, CFO. Ipsen Group decides on a former Shire Pharma CMO for Head, R&D and Bavarian Nordic names a vaccines commercial leader from GSK to be Chief Commercial Officer in 2020.

Appointments BioPharmaceutical

Execs On The Move, November 2019

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership

Executives On The Move: Santhera Pharmaceuticals Announces Its Next CEO And Checkmate And Imago Bring Aboard Business Leaders

Santhera Pharmaceuticals, developer of treatments for neuromuscular and pulmonary conditions, announces its next CEO, and cancer immunotherapy firm Checkmate Pharmaceuticals and neoplastic myeloid disease company Imago BioSciences each add a CBO.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register